HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian G Hartinger Selected Research

4-cymene (p-cymene)

1/2021Tracing the anticancer compound [RuII(η6-p-cymene)(8-oxyquinolinato)Cl] in a biological environment by mass spectrometric methods.
10/2018Understanding the interactions of diruthenium anticancer agents with amino acids.
7/2013Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
11/2009Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
9/2008The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian G Hartinger Research Topics

Disease

59Neoplasms (Cancer)
02/2022 - 06/2003
6Carcinoma (Carcinomatosis)
07/2013 - 01/2007
2Prostatic Neoplasms (Prostate Cancer)
10/2021 - 01/2021
2Hemolysis
01/2020 - 10/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Necrosis
03/2015
1Thrombosis (Thrombus)
03/2015
1Kidney Neoplasms (Kidney Cancer)
12/2010
1Leukemia
12/2010
1Malaria
02/2009
1Ascites
09/2008
1Colonic Neoplasms (Colon Cancer)
01/2008
1Adenocarcinoma
11/2007

Drug/Important Bio-Agent (IBA)

14LigandsIBA
10/2021 - 06/2003
11Cisplatin (Platino)FDA LinkGeneric
10/2019 - 05/2006
10RutheniumIBA
10/2018 - 06/2005
9PlatinumIBA
02/2021 - 06/2003
9MetalsIBA
01/2020 - 01/2008
6Coordination ComplexesIBA
03/2020 - 06/2003
54-cymene (p-cymene)IBA
01/2021 - 09/2008
5Antineoplastic Agents (Antineoplastics)IBA
11/2018 - 10/2008
5DNA (Deoxyribonucleic Acid)IBA
07/2018 - 12/2006
5Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2018 - 01/2008
5Pharmaceutical PreparationsIBA
10/2014 - 06/2003
4Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2008
4indazolium trans- (tetrachlorobis(1H- indazole)ruthenate (III))IBA
07/2014 - 03/2006
4IndazolesIBA
01/2009 - 06/2005
3Peptides (Polypeptides)IBA
02/2022 - 07/2013
3OsmiumIBA
02/2018 - 10/2014
3Biological ProductsIBA
12/2016 - 03/2015
2Histone Deacetylase InhibitorsIBA
10/2021 - 01/2021
2Cytostatic AgentsIBA
01/2021 - 01/2021
2Thioredoxin-Disulfide ReductaseIBA
03/2020 - 11/2018
2carbeneIBA
03/2020 - 11/2018
23-hydroxyflavoneIBA
07/2018 - 12/2012
2Human Serum AlbuminFDA LinkGeneric
12/2016 - 07/2007
2CymenesIBA
03/2013 - 11/2009
2diphenyl (biphenyl)IBA
03/2013 - 01/2013
2CarbohydratesIBA
01/2013 - 01/2008
2Ruthenium CompoundsIBA
11/2008 - 05/2008
1benzimidazoleIBA
10/2021
1pyridineIBA
10/2021
1RhodiumIBA
10/2021
1ChloridesIBA
10/2021
1Histone Deacetylases (Histone Deacetylase)IBA
01/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2021
1Oxygen (Dioxygen)IBA
01/2021
1Investigational DrugsIBA
10/2019
1AlkanesIBA
10/2018
1Paclitaxel (Taxol)FDA LinkGeneric
11/2017
1Taxoids (Taxanes)IBA
11/2017
1PlectinIBA
01/2017
1maleimideIBA
12/2016
1Biotin (Vitamin H)FDA Link
03/2015
1biotin receptorIBA
03/2015
1VitaminsIBA
03/2015
1Carboplatin (JM8)FDA LinkGeneric
03/2015
1Growth InhibitorsIBA
10/2014
1Heavy MetalsIBA
10/2014
1Platinum Compounds (Compounds, Platinum)IBA
10/2014
1phosphoramidic acidIBA
07/2014
1Carbon Nanotubes (Carbon Nanotube)IBA
02/2013
1BBR 3464 (BBR3464)IBA
01/2011
1ferroceneIBA
12/2010
1Alkenes (Olefins)IBA
12/2010
1Amino AcidsFDA Link
11/2009
1PyronesIBA
11/2009
1maltolIBA
11/2009
1dichloro(4- cymene)(1,3,5- triaza- 7- phosphatricyclo(3.3.1.1)decane)ruthenium(II)IBA
09/2008
1SugarsIBA
01/2008
12'-deoxyguanosine 5'-phosphate (dGMP)IBA
04/2007
1Carrier Proteins (Binding Protein)IBA
03/2006
1Reducing AgentsIBA
01/2006
1Serum AlbuminIBA
06/2005

Therapy/Procedure

6Drug Therapy (Chemotherapy)
03/2018 - 10/2007
6Therapeutics
11/2017 - 01/2008
1Castration
10/2021
1Oral Administration
01/2017
1Aftercare (After-Treatment)
04/2015